The "Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2020-2025" has been added to ResearchAndMarkets.com's offering.

This report contains a comprehensive listing of manufacturing and supply deals announced since 2020 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual manufacturing and supply contract documents as submitted to the Securities Exchange Commission by companies and their partners.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

The report provides access to manufacturing and supply deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter manufacturing and supply deals. Fully revised and updated, the report provides details of manufacturing and supply deals from 2020 to 2025.

The initial chapters of this report introduce the reader to the context and framework of the manufacturing and supply deals. Chapter 1 provides an introductory overview, and chapter 2 delves into trend analysis and discusses the advantages of different deal types. Chapter 3 explores the structure of these deals, while chapter 4 reviews the top agreements by value. Chapter 5 lists the top 25 most active dealmakers, and chapter 6 offers a detailed categorization of deals, organized by company, therapy, technology, and industry type. These chapters collectively offer a robust foundation and a comprehensive understanding of the manufacturing and supply deal landscape.

Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology provides the reader with the following key benefits:

• Understand deal trends since 2020
• Browse manufacturing and supply deals
• Benchmark analysis - identify market value of transactions
• Financials terms
• Directory of deals by company A-Z, therapy focus and technology type
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Access contract documents - insights into deal structures
• Due diligence - assess suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Analyzing contract agreements allows due diligence of:

• What are the rights granted or optioned?
• What rights are granted by the agreement?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are intellectual property rights handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Key Topics Covered:

Chapter 1 - Introduction

Chapter 2 - Trends in manufacturing and supply dealmaking

2.1. Introduction

2.2. Definition of manufacturing and supply deal

2.3. Trends in manufacturing and supply deals since 2020

2.3.1. Manufacturing and supply dealmaking by year, 2020-2025

2.3.2. Manufacturing and supply dealmaking by phase of development, 2020-2025

2.3.3. Manufacturing and supply dealmaking by industry sector, 2020-2025

2.3.4. Manufacturing and supply dealmaking by therapy area, 2020-2025

2.3.5. Manufacturing and supply dealmaking by technology type, 2020-2025

2.3.6. Manufacturing and supply dealmaking by most active company, 2020-2025

2.4. Reasons for entering into manufacturing and supply partnering deals

2.5. The future of manufacturing and supply deals

Chapter 3 - Overview of manufacturing and supply deal structure

3.1. Introduction

3.2. Manufacturing and supply agreement structure

Chapter 4 - Leading manufacturing and supply deals

4.1. Introduction

4.2. Top manufacturing and supply deals by value

Chapter 5 - Top 25 most active manufacturing and supply dealmakers

5.1. Introduction

5.2. Top 25 most active manufacturing and supply dealmakers

Chapter 6 - manufacturing and supply deals including contracts directory

6.1. Introduction

6.2. Manufacturing and supply deals with contracts 2020-2025

Deal directory

• Deal directory - manufacturing and supply dealmaking by companies A-Z
• Deal directory - manufacturing and supply dealmaking by therapy area
• Deal directory - manufacturing and supply dealmaking by technology type

Companies Featured

• 1ST Biotherapeutics
• Abbott Laboratories
• Actym Therapeutics
• Advent International
• Affinia Therapeutics
• AM-Pharma
• Amgen
• ANI Pharmaceuticals
• Arcturus Therapeutics
• Aruvant Sciences
• Astellas Pharma
• AzuraRx BioPharma
• Batavia Biosciences
• Bio-Thera Solutions
• Biocon
• Biogen
• BioInvent
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Casma Therapeutics
• Celcuity
• Cellular Goods
• Chime Biologics
• Clearmind Medicine
• Codagenix
• Curia
• Dynavax Technologies
• EnzymeWorks
• Eucure Biopharma
• Evotec
• Fujifilm
• Gilead Sciences
• Genentech
• Hitachi Chemical
• ImmunoGen
• Incyte
• Ionis Pharmaceuticals
• Janssen Pharmaceuticals
• Laboratory Corporation of America
• Lion TCR
• Merck KGaA
• Moderna
• Novartis
• Pfizer
• Roche
• Sanofi
• Sinovac Biotech
• Takeda Pharmaceutical
• Vaccibody
• Vertex Pharmaceuticals

For more information about this report visit https://www.researchandmarkets.com/r/p6pnwr

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250704462868/en/